The results show that Mogat1, Cidea, and Gpam were upregulated in liver of NASH mice, and that HDP intervention downregulated Mogat1, Cidea, and Gpam in liver tissues (Figure 5). Here, GPAM is linked to metabolic dysfunction-associated steatohepatitis.